Acasti Pharma Inc. ACST was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 45.12% since Jun 4.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acasti Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the healthcare sector include Akorn, Inc. AKRX, Mallinckrodt plc MNK and KaloBios Pharmaceuticals, Inc. KBIO. While Akorn and Mallinckrodt carry a Zacks Rank #1 (Strong Buy), KaloBios Pharmaceuticals holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACASTI PHARMA ACST: Get Free Report
AKORN INC AKRX: Free Stock Analysis Report
MALLINCKRODT PL MNK: Free Stock Analysis Report
KALOBIOS PHARMA KBIO: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
